Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Avyakta Kallam"'
Autor:
Stephen Spurgeon, Matthew Mei, Paul M. Barr, Jacqueline Barrientos, Sven de Vos, Richard Furman, Krish Patel, Philip Thompson, Michael Y. Choi, Avyakta Kallam, Siruo Wang, Uzor Ogbu, Patricia Marinello, Michael Wang
Publikováno v:
HemaSphere, Vol 7, p e54506b2 (2023)
Externí odkaz:
https://doaj.org/article/2376d173237d400ba7d058b36755fbeb
Autor:
Jasmine Zain, Avyakta Kallam
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
T cell lymphomas are a heterogenous group with varying biological and clinical features that tend to have poor outcomes with a few exceptions. They account for 10-15% of all non-Hodgkin lymphomas (NHL), and 20% of aggressive NHL. There has been littl
Externí odkaz:
https://doaj.org/article/709bc1b93eda4a3eb6bfedec54a6e9d9
Autor:
Audrey L. Smith, Alexandria P. Eiken, Sydney A. Skupa, Dalia Y. Moore, Lelisse T. Umeta, Lynette M. Smith, Elizabeth R. Lyden, Christopher R. D’Angelo, Avyakta Kallam, Julie M. Vose, Tatiana G. Kutateladze, Dalia El-Gamal
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 12, p 6712 (2022)
B-cell chronic lymphocytic leukemia (CLL) results from intrinsic genetic defects and complex microenvironment stimuli that fuel CLL cell growth through an array of survival signaling pathways. Novel small-molecule agents targeting the B-cell receptor
Externí odkaz:
https://doaj.org/article/ea779f77bf3145bca09d096c17da4db1
Publikováno v:
Rare Tumors, Vol 7, Iss 4 (2015)
Undifferentiated embryonal sarcoma of the liver (UESL) is a rare malignant hepatic tumor. A 47 year old male presented with symptoms of sour taste in his mouth, occasional nausea, indigestion and 15-pound weight loss over two months. He had an unrema
Externí odkaz:
https://doaj.org/article/4a178647d4774360b71b2e7b3d6ca54f
Autor:
Elizabeth A. Griffiths, Vivek Roy, Laura Alwan, Kimo Bachiashvili, John Baird, Rita Cool, Shira Dinner, Mark Geyer, John Glaspy, Ivana Gojo, Ashley Hicks, Avyakta Kallam, Wajih Zaheer Kidwai, Dwight D. Kloth, Eric H. Kraut, Daniel Landsburg, Gary H. Lyman, Anjlee Mahajan, Ryan Miller, Victoria Nachar, Seema Patel, Shiven Patel, Lia E. Perez, Adam Poust, Fauzia Riaz, Rachel Rosovsky, Hope S. Rugo, Shayna Simon, Sumithira Vasu, Martha Wadleigh, Kelly Westbrook, Peter Westervelt, Ryan A. Berardi, Lenora Pluchino
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:436-442
The NCCN Guidelines for Hematopoietic Growth Factors provide recommendations for the appropriate use of growth factors in the clinical management of febrile neutropenia (FN), chemotherapy-induced thrombocytopenia (CIT), and chemotherapy-induced anemi
Autor:
Steven M. Horwitz, Stephen Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Jonathan Brammer, Mark W. Clemens, Ahmet Dogan, Francine Foss, Paola Ghione, Aaron M. Goodman, Joan Guitart, Ahmad Halwani, Bradley M. Haverkos, Richard T. Hoppe, Eric Jacobsen, Deepa Jagadeesh, Allison Jones, Avyakta Kallam, Youn H. Kim, Kiran Kumar, Neha Mehta-Shah, Elise A. Olsen, Saurabh A. Rajguru, Sima Rozati, Jonathan Said, Aaron Shaver, Lauren Shea, Michi M. Shinohara, Lubomir Sokol, Carlos Torres-Cabala, Ryan Wilcox, Peggy Wu, Jasmine Zain, Mary Dwyer, Hema Sundar
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:285-308
Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of lymphoproliferative disorders arising from mature T cells, accounting for about 10% of non-Hodgkin lymphomas. PTCL-not otherwise specified is the most common subtype, followed by angioi
Autor:
R. Gregory Bociek, Michelle A. Fanale, Philip J. Bierman, Matthew A. Lunning, Avyakta Kallam, Mary Jo Lechowicz, Julie M. Vose, Swaminathan P. Iyer, Mridula Krishnan, James O. Armitage
Publikováno v:
Annals of Hematology. 101:335-340
Peripheral T-cell lymphomas (PTCL) are a unique subset of lymphomas with a poor prognosis due to limited treatment options. We performed a phase 1 study of carfilzomib in patients with relapsed/refractory PTCL to determine the safety profile and the
Autor:
Stephen E. Spurgeon, Matthew Mei, Paul M. Barr, Jacqueline C. Barrientos, Sven de Vos, Richard R. Furman, Krish Patel, Philip A. Thompson, Michael Y. Choi, Avyakta Kallam, Sirou Wang, Uzor C. Ogbu, Akash Nahar, Michael L. Wang
Publikováno v:
Blood. 140:6640-6641
Autor:
Zaid Al-Kadhimi, Samuel Pirruccello, Zartash Gul, Lori Maness-Harris, Vijaya Raj Bhatt, Krishna Gundabolu, Jane Yuan, Matthew Lunning, Gregory Bociek, Christopher D’Angelo, Avyakta Kallam, James Armitage, Khansa Abdullah, Angela Hunter, Sarah Mccaslin, Elizabeth Lyden, Lynnette Smith, Michael Callahan, Kathryn Cole, Steven Hinrichs, James Talmadge, Julie Vose
Publikováno v:
Bone marrow transplantation. 57(10)
Autor:
Elizabeth A. Griffiths, Martha Wadleigh, Pamela S. Becker, Mark B. Geyer, Peter Westervelt, Avyakta Kallam, Sumithira Vasu, Rita Cool, Ivana Gojo, Rachel P. Rosovsky, Laura M Alwan, Anna Brown, Dwight D. Kloth, Lia Perez, Gary H. Lyman, Peter T. Curtin, Hope S. Rugo, Eric H. Kraut, Kimo Bachiashvili, Wajih Zaheer Kidwai, Sudipto Mukherjee, Vivek Roy
Publikováno v:
J Natl Compr Canc Netw
Hematopoietic growth factors, including erythrocyte stimulating agents (ESAs), granulocyte colony-stimulating factors, and thrombopoietin mimetics, can mitigate anemia, neutropenia, and thrombocytopenia resulting from chemotherapy for the treatment o